Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study
- Gut, Published Online First: 24 March 2020 | http://dx.doi.org/10.1136/gutjnl-2019-320015
